Flagship Pioneering Inc.
Flagship Pioneering is a leading American life sciences venture capital company headquartered in Cambridge, Massachusetts. Founded in 1999 (originally as NewcoGen), the firm invents, incubates, and funds biotechnology and health-focused companies, having founded and built over 100 bioplatform companies such as Moderna and Editas Medicine. It employs a large team of scientist-entrepreneurs, business operators, and professionals, serving early-stage startups and portfolio companies in the life sciences and sustainability sectors.
Investment Strategy
Flagship Pioneering's investment strategy centers on creating and incubating breakthrough companies by generating bold "what-if" scientific questions and building novel bioplatforms in-house. The firm focuses on high-impact opportunities in biotechnology, health, and sustainability, often developing first-in-category business models to address significant global challenges. Their approach combines rigorous science with an entrepreneurial process, prioritizing the development of transformative technologies and enduring value through their unique, hands-on innovation model.
Top Holdings
Equity Positions (4)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
M MRNA | Moderna Inc | 47.60% | $127.8M | 4,632,149 | $15.27 | $27.59 | -$3.5M |
S SANA | Sana Biotechnology Inc | 25.42% | $68.3M | 25,001,856 | $33.47 | $2.73 | +$26.3M |
F FHTX | Foghorn Therapeutics Inc | 22.19% | $59.6M | 12,674,120 | $20.27 | $4.70 | +$13.3M |
M MCRB | Seres Therapeutics Inc | 4.78% | $12.8M | 1,155,850 | $11.11 | $11.11 | +$12.8M |